Assisted Fluid Management IDE Study
AFM
A Validation of the Assisted Fluid Management Feature
1 other identifier
interventional
330
1 country
10
Brief Summary
The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2018
CompletedFirst Posted
Study publicly available on registry
March 19, 2018
CompletedStudy Start
First participant enrolled
April 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2019
CompletedResults Posted
Study results publicly available
November 8, 2024
CompletedNovember 8, 2024
May 1, 2019
8 months
March 12, 2018
October 16, 2024
October 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effectiveness of the Assisted Fluid Management Feature
Stroke volume change meeting the clinician-selected fluid strategy
30 Day follow-up
Study Arms (1)
Assisted Fluid Management
EXPERIMENTALSubjects enrolled in the validation study will have their fluid management decisions guided by the Acumen™ Assisted Fluid Management Feature. The Principal Investigator will accept or decline fluid recommendations.
Interventions
Subjects enrolled in the validation study will have their fluid management decisions guided by the AFM Feature.
Eligibility Criteria
You may qualify if:
- Be ≥ 18 years of age
- Abdominal, pelvic, major peripheral vascular surgery expected to last \>2 hours post anesthesia induction
- Participate or have authorized representative participate in the Informed Consent process and sign/date the IRB approved informed consent form.
You may not qualify if:
- Are \< 18 years of age
- Emergent or cardiovascular surgical procedure
- Are pregnant
- Participation in any other drug, device, or biologic study concomitantly, or within the last 30 days (which may clinically interfere with this Clinical Study)
- Refusal of patient or authorized representative to sign consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Loma Linda Health University
Loma Linda, California, 92354, United States
University of California, Davis
Sacramento, California, 95817, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Stony Brook Medicine
Stony Brook, New York, 11794-8480, United States
Duke University
Durham, North Carolina, 27710, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Greenville Health System, Greenville Memorial Hospital
Greenville, South Carolina, 29605, United States
The University of Texas Southwestern at Clements
Dallas, Texas, 75390, United States
Related Publications (1)
Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008 Jul 12;372(9633):139-144. doi: 10.1016/S0140-6736(08)60878-8. Epub 2008 Jun 24.
PMID: 18582931BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Edwards Critical Care Clinical Affairs
- Organization
- Edwards Lifesciences
Study Officials
- STUDY DIRECTOR
Tina Abdelnour, MS, BSN
Edwards Lifesciences
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2018
First Posted
March 19, 2018
Study Start
April 19, 2018
Primary Completion
December 21, 2018
Study Completion
January 25, 2019
Last Updated
November 8, 2024
Results First Posted
November 8, 2024
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share